インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • ジャーナル目次
  • 研究聖書
  • 中国国家知識基盤 (CNKI)
  • シマゴ
  • ウルリッヒの定期刊行物ディレクトリ
  • 電子ジャーナルライブラリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • SWBオンラインカタログ
  • 仮想生物学図書館 (vifabio)
  • パブロン
  • ミアル
  • 科学インデックスサービス (SIS)
  • ユーロパブ
  • Google スカラー
このページをシェアする
ジャーナルチラシ
Flyer image

概要

Concerns Involving Nanobiotechnology in Contemporary Vaccines Include Nanobacteria, Nanocarriers, and Nanovaccines

Grisolia Christian

This review briefly discusses the issues with nanobiotechnology as it relates to the design and creation of novel vaccines using the most well-known nanocarriers, including those made by nature such as bacterial spores, virus-like particles, exosomes, and bacteriophages and by man such as Proteosomes, liposomes, virosomes, SuperFluids, and nanobeads, as well as the benefits and drawbacks Here, we concentrate on the creation of nano-based vaccines as "nanovaccines" for stimulating immune systems, as well as the anticipated benefits and drawbacks in comparison to currently available vaccines. We also discuss a possible nanorisk for vaccines, known as nanobacterial contamination.